ATI RN
ATI Fundamentals Proctored Exam 2023 Quizlet
1. During a client's first hospitalization, which of the following actions ensures the safety of the client?
- A. Keep unnecessary furniture out of the way
- B. Keep the lights on at all times
- C. Keep side rails up at all times
- D. Keep all equipment out of view
Correct answer: A
Rationale: During a client's first hospitalization, it is essential to keep unnecessary furniture out of the way to prevent obstacles and ensure a safe environment. This action helps reduce the risk of accidents or falls, promoting the client's safety and well-being. Keeping the lights on at all times may not be necessary and can disrupt the client's rest. Keeping side rails up at all times can restrict the client's movement and independence unnecessarily. Keeping all equipment out of view may hinder the healthcare team's ability to monitor and access necessary tools for providing care.
2. If a pair of monozygotic twins raised in the same environment end up being different from one another (e.g., interests, hobbies, etc.), it is highly likely due to:
- A. Cephalocaudal pattern
- B. Proximodistal pattern
- C. Cephamodistal pattern
- D. Gene-environment correlation
Correct answer: B
Rationale: The correct answer is B: Proximodistal pattern. Differences between monozygotic twins raised in the same environment are likely due to non-shared environmental influences, which lead to differences in interests, hobbies, and other individual characteristics. Choices A, C, and D are incorrect. Cephalocaudal pattern refers to the principle of development from head to toe, not relevant in explaining differences between twins. Cephamodistal pattern is not a recognized developmental term. Gene-environment correlation does not directly explain the differences between identical twins raised in the same environment.
3. A child with pyloric stenosis is having excessive vomiting. The nurse should assess for what potential complication?
- A. Hyperkalemia
- B. Hyperchloremia
- C. Metabolic acidosis
- D. Metabolic alkalosis
Correct answer: D
Rationale: Excessive vomiting in pyloric stenosis leads to the loss of stomach acid (hydrochloric acid), resulting in metabolic alkalosis, not hyperkalemia, hyperchloremia, or metabolic acidosis. Metabolic alkalosis is characterized by a higher pH level in the blood due to the loss of acid and a relative increase in bicarbonate. Hyperkalemia is an elevated level of potassium in the blood and is not directly related to excessive vomiting in pyloric stenosis. Hyperchloremia is an excess of chloride in the blood, which is not typically associated with this condition. Metabolic acidosis is a condition characterized by a lower pH level in the blood, caused by an excess of acid or a loss of bicarbonate, which is not the typical complication seen in pyloric stenosis with excessive vomiting.
4. The client is discussing sources of carbohydrates with a nurse recently diagnosed with diabetes. Which food(s) identified by the client indicate understanding? (SATA)
- A. Starch
- B. Fiber
- C. Sugar
- D. All of the above
Correct answer: D
Rationale: The correct answer is D because starch, fiber, and sugar are all sources of carbohydrates. Starchy foods like bread, rice, and potatoes contain starch; fruits, vegetables, and whole grains provide fiber; and sugars are found in sweet foods like fruits, honey, and desserts. Fatty acids and amino acids are not sources of carbohydrates, so choices A, B, and C are correct while choices A and B are incorrect.
5. A healthcare provider is caring for a client who has asthma and is experiencing wheezing. Which of the following medications should the healthcare provider administer?
- A. Fluticasone
- B. Montelukast
- C. Albuterol
- D. Ipratropium
Correct answer: C
Rationale: Albuterol is a short-acting beta-agonist bronchodilator used to quickly relieve bronchospasm in clients with asthma who are experiencing wheezing. Fluticasone is an inhaled corticosteroid used for long-term control of asthma symptoms and not for acute wheezing. Montelukast is a leukotriene receptor antagonist used for long-term asthma management, not for immediate relief of wheezing. Ipratropium is an anticholinergic bronchodilator used for chronic obstructive pulmonary disease (COPD) and not typically used as the first-line treatment for asthma exacerbation.